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Percutaneous coronary rotational angioplasty was at- 
tempted in 12 patients. The procedure was performed 
with a flexible rotating shaft with an abrasive tip, vary- 
ing in diameter from 1.25 to 3.5 mm, tracking along a 
central guide wire. Among the 12 patients (mean age 58 
years), 4 had a stenosis in the left anterior descending 
coronary artery and 8 a stenosis in the right coronary 
artery. After the guide wire crossed the stenosis, the 
abrasive tip was slowly advanced and several passes 
across the stenosis were made. The residual stenosis was 
measured with computerized automatic quantitative coro- 
nary angiography. Success was defined as a reduction of 
percent stenosis by >20%. If residual stenosis remained 
significant @-SO%), the procedure was completed by bal- 
loon dilation. The device could not be inserted in 2 of the 12 
patients. 
Five of the 10 patients underwent rotational angioplasty 
alone, and 5 had the procedure completed by balloon 
dilation. The stenosis was significantly enlarged from 0.56 
f 0.31 mm to 1.26 f 0.28 mm. The outline of the vessel 
appeared smooth and regular. 
There were no complications related to the procedure 
and all patients were free of symptoms when discharged 2 
to 3 days after the procedure. Thus, coronary rotational 
angioplasty is a simple and safe procedure allowing marked 
dilation of the narrowed segment. However, long-term 
follow-up is required for further evaluation. 
(.I Am Co11 Cardiol1989;14:1278-82) 
Over the last 10 years, it has been clearly demonstrated that 
percutaneous coronary balloon angioplasty is an efficient 
method of myocardial revascularization (1,2). However, 
restenosis, which occurs in 30% to 35% of cases, remains a 
major limitation to the long-term benefit of this procedure 
(3). Alternative techniques, most of them still investiga- 
tional, have, therefore, been proposed. The main goal of 
these new techniques is to remove totally or partially the 
atherosclerotic plaque rather than simply to dilate the vessel. 
In a few cases, vaporization of the plaque by laser energy 
has been attempted. Mechanical atherectomy, as proposed 
by Simpson et al. (4), is more attractive and the preliminary 
results in human beings are very promising. 
In this study, we describe a new technique of coronary 
rotational angioplasty with a device designed to remove 
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atherosclerotic material by the abrasive effect of its high 
speed rotating tip. The excellent results obtained with this 
technique in experimental animal models (5-7) and in human 
peripheral arteries (8,9) led us to treat coronary artery 
narrowing. In this study, we report our preliminary results in 
patients with coronary artery disease. 
Methods 
The coronary rotational device. The device (RotablatoP, 
Biophysics International) (Fig. 1) consists of a rotating 
abrasive burr of variable diameter (from 1.25 to 3.5 mm) that 
can be advanced over a thin (0.23 mm) stainless steel central 
guide wire. The last 2 cm of the wire is composed of 
radiopaque platinum spring. The abrasive surface of the tip 
is composed of 30 to 40 pm diamonds embedded in nickel. 
The central guide wire and the abrasive tip can be advanced 
independently. The steerable guide wire allows selection of 
the vessel and crossing of the stenosis but is fixed during 
rotation of the burr. The drive mechanism is rotated up to 
180,000 rpm by an air turbine. The drive shaft is housed in a 
4F Teflon sheath through which small volumes of saline 
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Figure 1. The rotational device. 
solution are infused during rotation to lubricate and cool the 
system, which is disposable. 
Procedure. The patients received nifedipine (60 mg) and 
aspirin (500 mg) the day before the procedure. Sedation was 
obtained with an intravenous injection of 50 mg of chlorodi- 
azepate. After administration of local anesthesia, a 9F 
sheath was inserted into the femoral artery. A standard 9F 
guiding catheter was placed into the ostium of the coronary 
artery to perform an initial angiogram made in three different 
projections after intracoronary injection of 2 mg of isosor- 
bide dinitrate. Then, 10,000 U of heparin was intravenously 
injected. The atherectomy device was introduced into the 
guiding catheter and positioned just before its distal tip. 
Under fluoroscopy, the steerable guide wire was advanced 
through the narrowing and directed into the distal part of the 
vessel. Then, the abrasive tip was advanced along the guide 
wire, placed in contact with the stenosis and the rotation was 
started. When an adequate speed of rotation was reached 
(150,000 to 180,000 rpm) the abrasive tip was advanced 
gently over the guide wire. If resistance was encountered, 
the tip was alternately advanced and withdrawn to maintain 
a high speed rotation. Once the abrasive tip crossed the 
lesion, it was pulled back and several passages were per- 
formed until the impression of mechanical resistance disap- 
peared. On average, the rotation was stopped after six to 
eight passages, and the abrasive tip was removed into the 
guiding catheter while the guide wire remained distally. 
After dye injection verified the results of the procedure, the 
rotational catheter and its guide wire were completely with- 
drawn. 
The protocol was approved by the Ethical Committee of 
the University of Lille, the French Ministry of Health and 
the United States Food and Drug Administration. All pa- 
tients gave informed consent. 
Coronary angiography. The angiographic results were 
assessed with computerized quantitative coronary angiogra- 
phy. The image of the vessel was digitized and three regions 
of interest (size 100 X 100 pixels) encompassing three 
arterial segments were selected. The edges of the arterial 
segments were automatically detected by the computer on 
the basis of the weighted sum of first and second derivative 
functions applied to the digitized brightness information. 
The results were expressed in absolute values (in millime- 
ters) by using the guiding catheter as a scaling device. 
Primary succe.rs of rotational angioplasty was defined as 
a significant reduction (>20%) of percent stenosis without 
complications. When the residual stenosis after rotational 
angioplasty remained significant (>50%), balloon angio- 
plasty completed the procedure. Within the first 24 h, several 
electrocardiograms (ECG) were recorded and serum creat- 
ine kinase was measured serially. 
Follow-up. The patients were discharged on a regimen of 
aspirin (500 mgiday) and nifedipine (60 mglday). They were 
restudied 3 months later with a treadmill exercise test (Bruce 
protocol) and underwent repeat coronary angiography. 
Study patients. Twelve patients, 10 men and 2 women 
with an average age of 58 years (range 46 to 69), underwent 
coronary rotational angioplasty. Six patients had a history of 
prior myocardial infarction. All complained of severe typical 
effort angina (mean duration 7 months) and 8 were in New 
York Heart Association functional class IV. No patient had 
prior coronary angioplasty or surgical bypass grafting. All 
patients had lesions suitable for myocardial revasculariza- 
tion. Coronary angiography showed single vessel disease in 
10 patients and double vessel disease in 2. The treated 
segment was located in the right coronary artery in eight 
patients and in the left anterior descending coronary artery 
in four. 
The mean diameter of the treated coronary stenosis was 
0.58 + 0.35 mm, and one patient had a subtotally occluded 
vessel. On average, the degree of luminal diameter reduction 
of the stenosis was 74 t 24%. The length of the narrowing 
averaged 8 + 3.2 mm. Two stenoses were calcified and three 
were eccentric. In two cases, the ergonovine test performed 
during prior coronary angiography induced spasm of the 
treated segment. 
At the beginning of our experience, the patients were 
selected on the basis of the morphology of the coronary 
stenosis. Thus, discrete, very tight, focal lesions were se- 
lected, and small size burrs were used, taking into account 
the mismatch between the large burrs (>1.75 mm) and the 
guiding catheter. Ultimately, the availability of “giant” 
lumen catheters allowed the use of a large burr and the size 
of the drill was carefully matched to the diameter of the 
proximal normal segment of the vessel. 
Statistics. All data are presented as mean values ? 1 SD. 
Differences in vessel diameter were analyzed by paired t 
test. A difference of p < 0.05 was considered statistically 
significant. 
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Figure 2. Immediate results of coronary rotational angioplasty in 12 
patients. In the two failures, the stenosis was not crossed by the 
guide wire. Resid. sten. = residual stenosis. 
Results 
Immediate results (Fig. 2). In two patients, the steerable 
guide wire was unable to pass through the narrowed vessel, 
and therefore, the device could not be inserted. In five 
patients, we used a small abrasive tip (< 1.50 mm). Although 
marked enlargement of the narrowed channel was obtained 
(from 0.43 ? 0.38 mm to 1.17 2 0.20 mm), the degree of 
residual stenosis (60 ? 13%) required us to complete the 
procedure with balloon dilation, after which the residual 
stenosis was nonsignificant. In five patients, rotational an- 
gioplasty alone yielded an excellent result with a nonsignif- 
icant (~50%) residual narrowing. In this group, the average 
Figure 3. Bight coronary artery before, during and after coronary 
rotational angioplasty. 1) Tight stenosis of the first segment of the 
right coronary artery. 2) Burr over the guide wire, which is beyond 
the narrowing. 3) Vessel after coronary rotational angioplasty show- 
ing smooth contours of the treated segment. 
absolute diameter of the stenosis increased from 0.72 ? 0.05 
mm to 1.4 ? 0.3 mm (p < 0.01). The percent of luminal 
narrowing significantly decreased from 73% to 46% 
(p < 0.01). A typical example is shown in Figure 3. 
Complications. There were no untoward incidents or 
major complications during the procedure. No patient expe- 
rienced chest pain or ST segment changes during rotational 
angioplasty. In three patients with a dominant right coronary 
artery, transient (few seconds) atrioventricular block oc- 
curred. During hospitalization, no patient developed chest 
pain, ECG changes or serum enzyme rise (mean creatine 
kinase = 28 + 14 international units). Nine of the 10 patients 
were discharged 2 or 3 days later. All nine, especially those 
with unstable angina, were in markedly improved condition 
and were free of symptoms at discharge. 
Four days after a successful rotational angioplasty of the 
left anterior descending coronary artery, one patient (a 69 
year old woman) developed an acute painful abdominal pain 
syndrome. She died 1 day later (5 days after the procedure). 
Autopsy revealed extensive mesenteric infarction without 
embolization. Careful study of the heart and left anterior 
descending coronary artery revealed no myocardial damage, 
a patent vessel and a smooth treated segment; again, there 
was no distal embolization. On scanning electron micros- 
copy the vessel surface was smooth, with thin furrows 
related to the drilling, and free of platelet deposition. 
Discussion 
New devices to remove atherosclerotic plaque. The main 
goal of the different techniques of myocardial revasculariza- 
tion is to restore adequate coronary flow by enlarging the 
atherosclerotic arterial lumen. This can be achieved by 
percutaneous balloon angioplasty, which increases the diam- 
eter of the vessel by several mechanisms including compres- 
sion, redistribution, disruption of the plaque and inelastic 
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Figure 4. Scanning electron micrograph of the left anterior descend- 
ing coronary artery from the patient who died of noncardiac causes 
5 days after rotational angioplasty. Transverse and superficial fur- 
rows 30 pm wide are present on the treated surface. There is no 
intimal flap or thrombus in the vessel lumen (original magnification 
x 100. reduced by 18%). 
stretching of the arterial wail. New methods that attempt to 
produce recanalization by removing atherosclerotic material 
are currently under investigation. These methods include 
vaporization of the plaque by laser energy; however, perfo- 
ration and thrombotic vessel occlusion are frequently ob- 
served with laser angioplasty. More interesting are atherec- 
tomy devices that remove the excise part of the atheroma. 
The initial results obtained by Simpson et al. (4) with a small 
and flexible coronary atherectomy catheter are already very 
promising, although the procedure is somewhat time con- 
suming. Another approach uses vascular drills. and several 
prototypes of these are being investigated. 
These new devices raise a question of semantics: is it 
right to call these techniques atherectomy? Usually the suffix 
“ectomy” means removal. The excisional method of Simp- 
son et al. (4) removes the atherosclerotic material from the 
coronary vessel and deserves the name of atherectomy. 
Rotational methods remove the plaque that is ground up by 
the abrasive head of the device. Should we call this method 
rotational athero-abrasion? In any case, the main purpose is 
to remove atherosclerotic material that is pulverized in small 
particles and therefore the word atherectomy rather than 
angioplasty could be applied. 
Previous studies with rotational angioplasty. Several ex- 
perimental studies. in vitro and in animals, were performed 
within the last 3 years. In 13 atherosclerotic rabbit iliac 
arteries, Hansen et al. (5) achieved a significant reduction of 
stenosis with rotary atherectomy. Only two complications 
occurred: one perforation related to the guide wire and an 
acute occlusion due to an oversized olive burr. Ahn et al. (6) 
demonstrated in human cadavers the capability of the device 
to transform calcified or fibrous plaques into a colloidal 
suspension composed of microparticles. generally smaller 
than 5 pm. They did not find embolic or necrotic sequelae 
after peripheral injection of ablation particle fragments into 
dogs. We recently reported (8) the histopathologic analysis 
of human peripheral arterial segments resected after rota- 
tional angioplasty. Scanning electron microscopy showed 
that the treated surface was smooth and polished with 
minimal thrombogenicity. In vivo, the first human rotational 
angioplasty was performed by Zacca et al. (9) in six patients 
with femoropopliteal stenosis. All the stenotic segments 
were crossed and treated successfully without complica- 
tions. In coronary arteries, Hansen et al. (7) showed in II 
normal canine coronary arteries that this high speed rotating 
abrasive technique could be safely applied and resulted in 
minimal vessel damage. Finally, our study reports the first 
preliminary experience in coronary arteries of humans (10). 
Problems related to the pulverization of the plaque. The 
system is designed to remove atherosclerotic stenosis by 
creating small particles. All the previous studies show that 
high speed rotation produces small particles. Analysis of 
particles produced by the abrasive tip in atherosclerotic 
aortas indicated that 98% of the particles produced were <IO 
pm diameter (6). In our study (8) performed in peripheral 
arteries, 75% of particles were <IO pm in diameter. Thus, 
the debris particles are too small to clog capillaries. In the 
present study, there was no clinical or angiographic evidence 
of distal coronary embolization because the patient did not 
develop ST segment changes or serum enzyme release. 
One limitation of this device could he the size of the 
abrasive tip. Obviously, the device should be introduced 
through a guiding catheter. Even in a 9F catheter, the inner 
diameter is only 2 mm and most often is 1.9 mm at the site of 
the connector. Therefore, the diameter of the new channel is 
most often limited to 1.75 mm. For a vessel with a diameter 
of 3 to 3.2 mm, the residual stenosis could be 45% to 50%. 
This limitation explains why in five cases the procedure was 
completed by balloon dilation. In the future, a guiding 
catheter with a larger diameter should allow the introduction 
of larger burrs able to open the narrowing up to a diameter of 
3 mm. 
Clinical implications. This preliminary study demon- 
strates that percutaneous coronary rotational angioplasty 
with a high speed rotational device is a safe procedure 
allowing successful angiographic and clinical results. How- 
ever, some technical improvements (flexibility of the central 
guide wire, guiding catheters with a larger inner lumen) 
should provide the interventional cardiologist a very useful 
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and rapid method for safe removal of atherosclerotic mate- 
rial. However, these encouraging results require further 
studies especially with regard to long-term follow-up results. 
We thank Catherine Gaillard for secretarial assistance. 
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